Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure

Verfasser / Beitragende:
[P. Pacher, L. Liaudet, J. Mabley, K. Komjati, C. Szabo]
Ort, Verlag, Jahr:
2002
Enthalten in:
Journal of the American College of Cardiology, 40/5(2002-09), 1006-16
Format:
Artikel (online)
ID: 439487110